The FDA didn’t outright reject the application, but requested for one more Section three scientific trial, that will probable consider several decades to finish and resubmit for the FDA. With Lykos going again on the drafting board, who’s likely to take the next swing at FDA acceptance?Donald Trump’s assure to try and do sweeping tariffs coul